Skip to main content
. 2020 Jul 11;45(1):27–34. doi: 10.1016/j.medin.2020.06.015

Table 1.

Demographic and clinical characteristics.

All (n = 44) IMV (n = 34) HFNC (n = 10) p
Age 61.50 (53.25 – 67) 62 (53.75 – 67.25) 59.5 (48.5 – 63.75) 0.320
Male 32 (72.7) 25 (73.5) 7 (70) 0.826
BMI 29 (25.6 – 31) 28.55 (24.5 – 31.1) 29.7 (27.5 – 31) 0.408
Comorbidities
 Arterial hypertension 23 (52.3) 18 (52.9) 5 (50) 0.870
 Diabetes mellitus 6 (13.6) 5 (14.7) 1 (10) 0.703
 Dyslipidemia 16 (36.4) 13 (38.2) 3 (30) 0.634
 Chronic corticotherapy 2 (4.5) 2 (5.9) 0 (0) 0.432
 Immunodeficiency 2 (4.5) 2 (5.9) 0 (0) 0.432
 Pneumopathy 5 (11.4) 3 (8.8) 2 (20) 0.328
Delay between onset of symptoms and hospitalization 6.5 (5 – 8) 6 (4 – 7.25) 7.5 (6 – 9.25) 0.050
Delay between hospitalization and MCCU admission 2 (0 – 4) 1.5 (0 – 3.25) 2 (1.75 – 5) 0.142
SAPS3 50 (43.50 – 59) 53 (42.75 – 62.25) 45.5 (44 – 49.25) 0.052
Norepinephrine 28 (63.6) 27 (79.4) 1 (10) < 0.001
RRT 1 (2.3) 1 (2.9) 0 (0) 0.703
MCCU stay 14 (8 – 23.25) 19 (13 – 25.75) 6 (4.75 – 8.5) < 0.001
Hospital stay 23 (15 – 28)* 26 (19.29)* 17.5 (14.25 – 22.5) 0.079
Mortality 8 (18.1)* 8 (23.5)* 0 (0) 0.080

Data expressed as mean ± standard deviation or number (%), unless otherwise specified. BMI, body mass index; HFNC, high flow nasal cannula; IMV, invasive mechanical ventilation; MCCU, Medical Critical Care Unit; RRT, renal replacement therapy; SAPS, Simplified Acute Physiology Score.

*

3 patients still remain at the MCCU.